Intec Capital (526871)
Score breakdown: P/E: 3/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹16.45 |
| Market Cap | ₹30.21 Cr |
| P/E Ratio | 3.54 |
| ROCE | 2.8% |
| ROE | 15.69% |
| Dividend Yield | 0% |
| Profit Growth | 40% |
| Debt/Equity | — |
| Sales Growth | 373.17% |
| 52-Week Range | ₹8.67 — ₹17.99 |
| Sector | Finance |
| Book Value | ₹17.8 |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
At first glance, Intec Capital catches my eye the way a beaten-down asset often does. The market price is ₹16.45, while book value is ₹17.80, so I am buying at a discount to stated net assets. The reported P/E of 3.54 and PEG of 0.02 look almost too cheap, and a Piotroski score of 7 out of 9 suggests the underlying business is improving. But I have to remember what I am really buying. This is a ₹30 crore NBFC, with quarterly sales of just ₹2 crore and net profit of zero in the latest quarter. A small lender has no economic moat; its raw material is money and its product is credit, so management, asset quality, and leverage decide everything. Here, debt-to-equity is not disclosed, and promoter holding is also not available. I cannot judge a bank-like business without seeing the quality of its loan book or the safety of its capital structure. The 373% sales growth is flattering on a tiny base; profit growth of 40% is nice, but the absolute numbers are trivial. ROE of 15.69% is respectable, yet ROCE of only 2.80% tells me the return on capital is weak. The dividend is zero, so I am relying entirely on asset value appreciation and eventual earnings power. At this price, the margin of safety is thin, not deep. I would not call this a wonderful business; it is a speculative small-cap recovery situation. The stock is near the upper end of its 52-week range, so the market has already noticed the improvement. I would need to see consistent quarterly profits, clean asset quality, and real transparency before committing a rupee. If those things arrive, this could be an interesting turnaround; until then, it is only a watch-list case.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer